Figure 1
Targets for DBS in epilepsy. 3D representation of anatomical seeds of DBS targets used for the treatment of epilepsy is shown on sagittal and axial 7-Tesla T1 MRI slices of the human brain (100 μm resolution in MNI152 space). Mean seizure reduction that was calculated from our systematic literature review is shown for ANT – 60%, CMT – 69%, and HC – 65%. Based on our systematic review, higher quality of evidence exists for the use of ANT-DBS in DRE. Other DBS targets that belong to known cortico-subcortical circuits are visualized on the figure.

Targets for DBS in epilepsy. 3D representation of anatomical seeds of DBS targets used for the treatment of epilepsy is shown on sagittal and axial 7-Tesla T1 MRI slices of the human brain (100 μm resolution in MNI152 space). Mean seizure reduction that was calculated from our systematic literature review is shown for ANT – 60%, CMT – 69%, and HC – 65%. Based on our systematic review, higher quality of evidence exists for the use of ANT-DBS in DRE. Other DBS targets that belong to known cortico-subcortical circuits are visualized on the figure.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close